Borut Štrukelj

Title: Borut Štrukelj: Innovator in Allergy Therapy

Introduction

Borut Štrukelj is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of allergy therapy through his innovative research and patents. His work focuses on developing solutions to combat allergic reactions, which affect millions of people worldwide.

Latest Patents

Borut Štrukelj holds a patent for "IgE epitope-like peptides and uses thereof." This invention relates to IgE epitope-like peptides that have the ability to bind to allergen-specific IgE paratopes. These allergen-specific IgEs are bound to effector cells of allergic patients. The peptides developed by Štrukelj cover the paratopes of the IgE bound on effector cells, preventing the binding of the causative allergen. This mechanism helps to prevent degranulation and the secretion of mediators of allergic inflammation from effector cells upon contact with the allergen. The invention also outlines methods for using these peptides in the therapy of allergic reactions caused by exposure to allergens.

Career Highlights

Throughout his career, Borut Štrukelj has worked with esteemed institutions such as the University of Ljubljana and the University Clinic of Respiratory and Allergic Diseases. His research has been pivotal in advancing the understanding and treatment of allergic conditions.

Collaborations

Štrukelj has collaborated with notable colleagues, including Mojca Lunder and Peter Korošec. These partnerships have contributed to the success of his research and the development of innovative therapeutic approaches.

Conclusion

Borut Štrukelj's contributions to allergy therapy through his patented inventions highlight his role as a leading innovator in the field. His work continues to impact the lives of those suffering from allergies, paving the way for future advancements in treatment.